Clinical Trial Update: Iron, Alpha-Synuclein, and Lymphocyte-activation Gene-3 in Ischemic Stroke

View source ↗

Summary

A completed clinical trial investigates iron, alpha-synuclein, and LAG-3 in ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Aswan University Hospital | Conditions: Brain Ischemia | Status: COMPLETED